Articles

Large-scale production of advanced biofuels beyond the level of the Renewable Fuel Standard is achievable and sustainable by 2030.

Since the commercialization of biotechnology in 1996, farmers have used this science to grow plants that yield more per acre with reduced production costs while being resistant to disease and pests and also beneficial to the environment.

In the near future, we’ll see crops that will be resistant to environmental stresses like drought and crops that use soil nutrients more efficiently, boosting productivity in areas of the world with inadequate rainfall or poor soil.

Read the fact sheet

Genetic disorders known as Lysosomal Storage Diseases, including Gaucher disease, Fabry disease and Pompe disease, continue to be an area of high unmet medical need.

In a presentation at International Science Attachés Briefing, Matthew Carr outlines how the "third wave" in biotechnology can help reduce greenhouse gas emissions.

BIO supports the following three principles, and believes that each is a vital step toward meaningful health care reform and providing a solution to the nation’s health care crisis. BIO believes that each principle is equally important, that they are inextricably intertwined, and that any meaningful health care reform proposal must address all three. Specifically, BIO believes:

To apply to be a BIO member, please fill out our online membership application

Please feel free to contact our membership department with any questions:

Karen Hurst
khurst[at]bio.org
202-280-1639
Coordinator, Membership

Rosemary Garcia
rgarcia[at]bio.org
202-962-9208
Manager, Membership & Customer Service

Elizabeth Gaskins
egaskins[at]bio.org
Director, Membership

BIO Principles on Clinical Trials

Adopted by BIO's Clinical Safety and Efficacy Committee in 2008

SYNBIOSAFE is a project in Europe to research the safety and ethical aspects of synthetic biology, and aims to proactively stimulate a debate on these issues.